DNB Fund - Biotechnology N (ACC) EUR

WKN A40FC8 | ISIN LU2814038340 |  Fonds
Factsheet

Fonds

ISIN Name Performance Volatilität Sharpe Ratio
1 LU0195948822 Franklin Biotechnology Discovery Fund - I (acc) USD +49,19 % +24,47 % 1,92
2 LU0976566496 Franklin Biotechnology Discovery Fund - W (acc) USD +49,12 % +24,49 % 1,92
3 LU0258985083 Pictet - Biotech - Z USD +51,57 % +26,10 % 1,89
4 LU0109394709 Franklin Biotechnology Discovery Fund - A (acc) USD +47,91 % +24,46 % 1,87
5 LU2208649280 UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse QL-acc, USD +42,65 % +22,06 % 1,84
74 LU2814038340 DNB Fund - Biotechnology N (ACC) EUR +20,04 % +24,67 % 0,73
83 LU0415392678 Bellevue Funds (Lux) - Bellevue Obesity Solutions I EUR - Accumulating +0,18 % +14,00 % -0,14
84 LU0415392249 Bellevue Funds (Lux) - Bellevue Obesity Solutions B EUR - Accumulating -0,51 % +14,00 % -0,19
85 LU2719280096 Bellevue Funds (Lux) - Bellevue Obesity Solutions I2 CHF - Accumulating -5,95 % +14,98 % -0,54
86 LU0415392835 Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating -6,08 % +14,98 % -0,55
87 LU0415392595 Bellevue Funds (Lux) - Bellevue Obesity Solutions B CHF - Accumulating -6,73 % +14,98 % -0,59